The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Dalfampridine Market Research Report 2025
Synopsis
Dalfampridine is a potassium channel blocker used to help multiple sclerosis patients walk. This is the first drug that was specifically approved to help with mobility in these patients.
The global Dalfampridine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Dalfampridine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Dalfampridine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Dalfampridine include Acorda Therapeutics, Elan Pharma, Biogen, Sun Pharmaceutical and Aurobindo Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Dalfampridine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dalfampridine.
Report Scope
The Dalfampridine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dalfampridine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dalfampridine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Acorda Therapeutics
Elan Pharma
Biogen
Sun Pharmaceutical
Aurobindo Pharma
Segment by Type
10 mg
Others
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dalfampridine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Dalfampridine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Dalfampridine is a potassium channel blocker used to help multiple sclerosis patients walk. This is the first drug that was specifically approved to help with mobility in these patients.
The global Dalfampridine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Dalfampridine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Dalfampridine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Dalfampridine include Acorda Therapeutics, Elan Pharma, Biogen, Sun Pharmaceutical and Aurobindo Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Dalfampridine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dalfampridine.
Report Scope
The Dalfampridine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dalfampridine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dalfampridine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Acorda Therapeutics
Elan Pharma
Biogen
Sun Pharmaceutical
Aurobindo Pharma
Segment by Type
10 mg
Others
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dalfampridine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Dalfampridine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Dalfampridine Market Overview
1.1 Product Overview and Scope of Dalfampridine
1.2 Dalfampridine Segment by Type
1.2.1 Global Dalfampridine Market Value Comparison by Type (2024-2030)
1.2.2 10 mg
1.2.3 Others
1.3 Dalfampridine Segment by Application
1.3.1 Global Dalfampridine Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Dalfampridine Market Size Estimates and Forecasts
1.4.1 Global Dalfampridine Revenue 2019-2030
1.4.2 Global Dalfampridine Sales 2019-2030
1.4.3 Global Dalfampridine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Dalfampridine Market Competition by Manufacturers
2.1 Global Dalfampridine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Dalfampridine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Dalfampridine Average Price by Manufacturers (2019-2024)
2.4 Global Dalfampridine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Dalfampridine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dalfampridine, Product Type & Application
2.7 Dalfampridine Market Competitive Situation and Trends
2.7.1 Dalfampridine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Dalfampridine Players Market Share by Revenue
2.7.3 Global Dalfampridine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dalfampridine Retrospective Market Scenario by Region
3.1 Global Dalfampridine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Dalfampridine Global Dalfampridine Sales by Region: 2019-2030
3.2.1 Global Dalfampridine Sales by Region: 2019-2024
3.2.2 Global Dalfampridine Sales by Region: 2025-2030
3.3 Global Dalfampridine Global Dalfampridine Revenue by Region: 2019-2030
3.3.1 Global Dalfampridine Revenue by Region: 2019-2024
3.3.2 Global Dalfampridine Revenue by Region: 2025-2030
3.4 North America Dalfampridine Market Facts & Figures by Country
3.4.1 North America Dalfampridine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Dalfampridine Sales by Country (2019-2030)
3.4.3 North America Dalfampridine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Dalfampridine Market Facts & Figures by Country
3.5.1 Europe Dalfampridine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Dalfampridine Sales by Country (2019-2030)
3.5.3 Europe Dalfampridine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dalfampridine Market Facts & Figures by Country
3.6.1 Asia Pacific Dalfampridine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Dalfampridine Sales by Country (2019-2030)
3.6.3 Asia Pacific Dalfampridine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Dalfampridine Market Facts & Figures by Country
3.7.1 Latin America Dalfampridine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Dalfampridine Sales by Country (2019-2030)
3.7.3 Latin America Dalfampridine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dalfampridine Market Facts & Figures by Country
3.8.1 Middle East and Africa Dalfampridine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Dalfampridine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Dalfampridine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dalfampridine Sales by Type (2019-2030)
4.1.1 Global Dalfampridine Sales by Type (2019-2024)
4.1.2 Global Dalfampridine Sales by Type (2025-2030)
4.1.3 Global Dalfampridine Sales Market Share by Type (2019-2030)
4.2 Global Dalfampridine Revenue by Type (2019-2030)
4.2.1 Global Dalfampridine Revenue by Type (2019-2024)
4.2.2 Global Dalfampridine Revenue by Type (2025-2030)
4.2.3 Global Dalfampridine Revenue Market Share by Type (2019-2030)
4.3 Global Dalfampridine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Dalfampridine Sales by Application (2019-2030)
5.1.1 Global Dalfampridine Sales by Application (2019-2024)
5.1.2 Global Dalfampridine Sales by Application (2025-2030)
5.1.3 Global Dalfampridine Sales Market Share by Application (2019-2030)
5.2 Global Dalfampridine Revenue by Application (2019-2030)
5.2.1 Global Dalfampridine Revenue by Application (2019-2024)
5.2.2 Global Dalfampridine Revenue by Application (2025-2030)
5.2.3 Global Dalfampridine Revenue Market Share by Application (2019-2030)
5.3 Global Dalfampridine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Acorda Therapeutics
6.1.1 Acorda Therapeutics Corporation Information
6.1.2 Acorda Therapeutics Description and Business Overview
6.1.3 Acorda Therapeutics Dalfampridine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Acorda Therapeutics Dalfampridine Product Portfolio
6.1.5 Acorda Therapeutics Recent Developments/Updates
6.2 Elan Pharma
6.2.1 Elan Pharma Corporation Information
6.2.2 Elan Pharma Description and Business Overview
6.2.3 Elan Pharma Dalfampridine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Elan Pharma Dalfampridine Product Portfolio
6.2.5 Elan Pharma Recent Developments/Updates
6.3 Biogen
6.3.1 Biogen Corporation Information
6.3.2 Biogen Description and Business Overview
6.3.3 Biogen Dalfampridine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Biogen Dalfampridine Product Portfolio
6.3.5 Biogen Recent Developments/Updates
6.4 Sun Pharmaceutical
6.4.1 Sun Pharmaceutical Corporation Information
6.4.2 Sun Pharmaceutical Description and Business Overview
6.4.3 Sun Pharmaceutical Dalfampridine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sun Pharmaceutical Dalfampridine Product Portfolio
6.4.5 Sun Pharmaceutical Recent Developments/Updates
6.5 Aurobindo Pharma
6.5.1 Aurobindo Pharma Corporation Information
6.5.2 Aurobindo Pharma Description and Business Overview
6.5.3 Aurobindo Pharma Dalfampridine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Aurobindo Pharma Dalfampridine Product Portfolio
6.5.5 Aurobindo Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dalfampridine Industry Chain Analysis
7.2 Dalfampridine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dalfampridine Production Mode & Process
7.4 Dalfampridine Sales and Marketing
7.4.1 Dalfampridine Sales Channels
7.4.2 Dalfampridine Distributors
7.5 Dalfampridine Customers
8 Dalfampridine Market Dynamics
8.1 Dalfampridine Industry Trends
8.2 Dalfampridine Market Drivers
8.3 Dalfampridine Market Challenges
8.4 Dalfampridine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
